DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens of various pathogens as genetically engineered vaccines both preventive and ther...
Saved in:
Main Authors: | L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-08-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1307 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
by: L. V. Cherenova, et al.
Published: (2017-05-01) -
Developing the next-generation of adenoviral vector vaccines
by: Alexander T. Sampson, et al.
Published: (2025-12-01) -
Features of a clinical course of the acute respiratory diseases caused by adenoviruses of epidemic significant serotypes
by: N. I. L`vov, et al.
Published: (2014-09-01) -
Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever
by: O. Popova, et al.
Published: (2025-01-01) -
Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
by: E. P. Kharchenko
Published: (2020-11-01)